---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-24-000017"
form_type: "8-K/A"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2024-02-06T23:59:59+00:00"
generated_at: "2026-06-06T08:36:09.778046+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare Q4 rev $5.2B (+5% organic), adj EPS $1.18; FY2024 adj EPS guide $4.20-$4.35

## Summary
- Q4 revenue $5.2B, up 5% organic YoY; net income $403M ($0.88 EPS) vs $554M ($1.21) prior year.
- Adjusted EBIT margin 16.1% in Q4, flat vs standalone prior year; full year adj EBIT margin 15.1% vs 14.5% standalone prior year.
- Full year revenue $19.6B (+7% reported, +8% organic); orders book-to-bill 1.03x.
- 2024 guidance: organic rev growth ~4%, adj EBIT margin 15.6%-15.9%, adj EPS $4.20-$4.35, FCF ~$1.8B.
- Repaid $850M debt in Q4, $150M in Jan 2024; announced agreement to acquire MIM Software (no value disclosed).

## SEC filing metadata
- accession: 0001932393-24-000017
- form_type: 8-K/A
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2024-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/gehc-20240206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-24-000017
- JSON: https://secwatch.observer/filing/0001932393-24-000017.json
- Plain text: https://secwatch.observer/filing/0001932393-24-000017.txt

## Key facts
- Earnings Releases
  GE HealthCare Technologies Inc. reported fourth quarter ended December 31, 2023 results: revenue $5.2 billion, net income $403 million, EPS $0.88.
  - Period: fourth quarter ended December 31, 2023
  - Revenue: $5.2 billion
  - Net income: $403 million
  - EPS: $0.88
  - Result: reported results
  source text: growth. We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape.” Fourth Quarter 2023 Total Company Financial Performance • Revenues of $5.2 billion increased 5% on both a reported and Organic* basis year-over-year, driven by price and volume. • Total company book-to-bill was strong at 1.05 times, defined as Total orders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm
- Earnings Releases
  GE HealthCare Technologies Inc. reported the fiscal year ended December 31, 2023 results: revenue $19.6 billion, net income $1.6 billion, EPS $3.04. Guidance reaffirmed.
  - Period: the fiscal year ended December 31, 2023
  - Revenue: $19.6 billion
  - Net income: $1.6 billion
  - EPS: $3.04
  - Guidance: reaffirmed
  - Result: reported results
  source text: million versus $109 million for the prior year. • Segment EBIT margin was 24.4% versus 23.0% for the prior year. Full Year 2023 Total Company Financial Performance • Revenues of $19.6 billion increased 7% year-over-year and 8% on an Organic* basis with growth across all segments and regions. • Total company book-to-bill was 1.03 times, as orders dollars outpaced
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.